Free Trial

iTeos Therapeutics (ITOS) SEC Filings & 10K Form

iTeos Therapeutics logo
$8.32 +0.19 (+2.34%)
(As of 11/22/2024 ET)

Recent iTeos Therapeutics SEC Filings

DateFilerForm TypeView
11/21/2024
7:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G
11/19/2024
6:59 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:57 AM
Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
11/18/2024
8:57 PM
Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
11/14/2024
5:04 PM
EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:08 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
6:00 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
8:49 PM
Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
10/15/2024
6:20 PM
Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
09/30/2024
8:00 AM
iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
09/16/2024
6:00 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:00 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:08 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
6:16 AM
Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2024
6:19 AM
Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Hallal David (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:01 PM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:37 AM
Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
05/14/2024
8:32 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:06 PM
iTeos Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:10 PM
iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
05/13/2024
6:01 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
3:35 PM
iTeos Therapeutics (Filer)
Form 424B5
05/10/2024
7:31 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
6:13 AM
iTeos Therapeutics (Filer)
Form ARS
04/25/2024
6:03 AM
iTeos Therapeutics (Filer)
Form DEF 14A
04/25/2024
6:07 AM
iTeos Therapeutics (Filer)
Form DEFA14A
03/08/2024
6:57 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:58 PM
iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:00 PM
Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:01 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
7:00 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2024
7:01 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:09 AM
iTeos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
03/06/2024
6:19 AM
iTeos Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/16/2024
11:54 AM
EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G
02/14/2024
8:45 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G/A
01/10/2024
4:00 PM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:26 PM
iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
12/07/2023
7:20 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:21 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:22 PM
Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:22 PM
iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:16 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
7:17 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ITOS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners